There may be more than one reason for the partial protection against blindness associated with GLP-1 RA, especially since this occurs even over the short term
The American Diabetes Association has issued strong warnings against using non-FDA-approved compounded GLP-1 and dual GIP/GLP-1 products, and the same caution applies even more strongly to investigational medications like retatrutide
A staggering 90% of vegetarians and vegans worldwide are estimated to have low B12 levels
MOTS-c offers a different mechanism that might appeal to those seeking alternatives or additions to GLP-1-based approaches
Most commercial insurers recognize J3420 as the correct HCPCS code for cyanocobalamin, but whether the injection itself is covered depends on the plans specific benefit design, the documented diagnosis, and whether prior authorization is required
Heat therapy, ice application, physical therapy, and low-impact exercise also reduce pain and inflammation without pharmaceutical risk